THE EFFECT OF THE SPECIFIC PHOSPHODIESTERASE (PDE) INHIBITORS ON HUMAN AND RABBIT CAVERNOUS TISSUE IN VITRO AND IN VIVO
- 1 April 1998
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 159 (4), 1390-1393
- https://doi.org/10.1016/s0022-5347(01)63622-x
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Intracavernous pharmacotherapyWorld Journal of Urology, 1997
- Cyclic nucleotide phosphodiesterase in human cavernous smooth muscleWorld Journal of Urology, 1997
- Nitric Oxide: A Physiologic Mediator of Penile ErectionScience, 1992
- Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic NeurotransmissionNew England Journal of Medicine, 1992
- Preliminary report on the effect of the nitric oxide donor SIN-1 on human cavernous tissue in vivoWorld Journal of Urology, 1991
- Effects of the nitric oxide synthase inhibitor NG‐nitro‐L‐arginine on the erectile response to cavernous nerve stimulation in the rabbitActa Physiologica Scandinavica, 1991
- Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscleBiochemical and Biophysical Research Communications, 1990
- Auto-Injection of the Corpus Cavernosum with a Vasoactive Drug Combination for Vasculogenic ImpotenceJournal of Urology, 1985
- Cavernosal Alpha-Blockade: A New Technique for Investigating and Treating Erectile ImpotenceThe British Journal of Psychiatry, 1983
- INTRACAVERNOUS INJECTION OF PAPAVERINE FOR ERECTILE FAILUREThe Lancet, 1982